Related Experiment Video
Updated: Aug 2, 2026

A Doxorubicin-Induced Murine Model of Dilated Cardiomyopathy In Vivo
Published on: May 16, 2020
[The etiology and pathogenesis of dilated cardiomyopathy]
Insights
Dilated cardiomyopathy may stem from a systemic immune issue, as indicated by connective tissue changes and immune complexes in skin biopsies. These findings were less common in hypertrophic cardiomyopathy patients.
Area of Science:
- Cardiology
- Immunology
- Pathology
Background:
- Cardiomyopathies are heart muscle diseases of unknown origin.
- Dilated cardiomyopathy (DCM) and hypertrophic cardiomyopathy (HCM) are distinct forms.
- Systemic involvement in cardiomyopathies is not fully understood.
Purpose of the Study:
- To investigate the potential systemic origins of cardiomyopathies.
- To examine skin biopsies for signs of systemic disease in DCM and HCM patients.
- To correlate findings with circulating immune complex levels.
Main Methods:
- Analysis of skin biopsies from patients with DCM and HCM.
- Morphological examination of connective tissue in skin biopsies.
- Measurement of circulating immune complexes in patient blood samples.
Main Results:
- DCM patients frequently exhibited morphological signs of systemic connective tissue disease.
- Elevated levels of circulating immune complexes were observed in DCM patients.
- Similar systemic changes were found in only one HCM patient, suggesting a difference in etiology.
Conclusions:
- Dilated cardiomyopathy is often a manifestation of a systemic immunopathological process.
- Skin biopsy findings suggest a broader connective tissue involvement in DCM.
- The etiology of HCM may differ significantly from DCM, with less evidence of systemic immune involvement.
Abstract:
The authors analyze cardiomyopathies as primary lesions of the heart of unknown etiology. Examination of skin biopsies in patients with dilated cardiomyopathy indicates the presence of morphological signs of the systemic character of the process in the connective tissue, an increased content of circulating immune complexes in the blood of patients. In hypertrophic cardiomyopathy similar changes were found only in one patient. Dilated cardiomyopathy is a manifestation of a systemic immunopathological process in most of these patients.
Related Concept Videos
Myocarditis I: Introduction
Heart Failure II: Pathophysiology
Cardiomyopathy I: Introduction and Classification
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

